Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1978
[Bone scintigraphy in Paget's disease]B Mazières, M Jung-Rosenfarb, G Bouteiller, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1989
Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivoM Galinier, J M Senard, P Valet, et al.
Thrombosis and Haemostasis|June 30, 1989
Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbitL Briant, C Caranobe, S Saivin, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
[Importance of standardization in the biological monitoring of anti-vitamin K therapy]F Forestier, B Boneu, G Potron, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Long-term persistence of low-molecular-weight material with anti-factor Xa activity contributes to anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbitV Peyrou, J C Lormeau, J P Hérault, et al.
Circulation|June 22, 2000
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humansY Cadroy, J P Bossavy, C Thalamas, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1984
Exhausted platelets in patients with malignant solid tumors without evidence of active consumption coagulopathyB Boneu, R Bugat, A Boneu, et al.
Thrombosis and Haemostasis|December 29, 1984
Exercise-induced platelet activation in myocardial infarction survivors with normal coronary arteriogramP Douste-Blazy, P Sié, B Boneu, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Pharmacodynamics of CY 216 in healthy volunteers: inter-individual variationsM Rostin, J L Montastruc, G Houin, et al.
Thrombosis and Haemostasis|November 1, 1995
A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosisA Diquélou, D Dupouy, R Cariou, et al.
Pageof 19